BiotechTubeBiotechTube
Home/CNS Pharmaceuticals/Dylan Wenke
DW

Dylan Wenke

Chief Business Officer

CNS Pharmaceuticals

Therapeutic Areas

NeurologyOncology

CNS Pharmaceuticals Pipeline

DrugIndicationPhase
TPI-287 (Abeotaxane)Recurrent Glioblastoma, Neuroblastoma, Medulloblastoma, Refractory Prostate Cancer, Tauopathy Disease (Dementia)Phase 2
BerubicinGlioblastomaPhase 2/3

Leadership Team at CNS Pharmaceuticals

RL
Rami Levin
President & Chief Executive Officer
SO
Steve O'Loughlin
Chief Financial Officer
LK
Lynne Kelley
Chief Medical Officer
EF
Eric Faulkner
Chief Technology Officer
FC
Faith Charles
Chair of the Board of Directors
JR
Jeffry R. Keyes
Director
BM
Bettina M. Cockroft
Director
AM
Amy Mahery
Director
J(
Jerzy (George) Gumulka
Director
View full CNS Pharmaceuticals profile